96 related articles for article (PubMed ID: 835372)
21. Diabetes and the myo-inositol paradox.
Loy A; Lurie KG; Ghosh A; Wilson JM; MacGregor LC; Matschinsky FM
Diabetes; 1990 Oct; 39(10):1305-12. PubMed ID: 2210080
[TBL] [Abstract][Full Text] [Related]
22. [Biochemical and clinical aspects of myoinositol].
Trznadel K; Lutz W
Pol Tyg Lek; 1976 Oct; 31(43):1857-9. PubMed ID: 790345
[No Abstract] [Full Text] [Related]
23. Acute effects of insulin on plasma noradrenaline and the cardiovascular system.
Christensen NJ; Gundersen HJ; Hegedüs L; Jacobsen F; Mogensen CE; Osterby R; Vittinghus E
Metabolism; 1980 Nov; 29(11 Suppl 1):1138-45. PubMed ID: 7001180
[TBL] [Abstract][Full Text] [Related]
24. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.
Tuttle KR; Bruton JL; Perusek MC; Lancaster JL; Kopp DT; DeFronzo RA
N Engl J Med; 1991 Jun; 324(23):1626-32. PubMed ID: 2030719
[TBL] [Abstract][Full Text] [Related]
25. [Simple method of quantitative determination of myoinositol in the serum and urine].
Lutz W; Trznadel K; Walasek L
Pol Tyg Lek; 1976 May; 31(17):711-3. PubMed ID: 934940
[No Abstract] [Full Text] [Related]
26. Tubular reabsorption of glucose in quantifying the relation between blood glucose and urinary glucose excretion in diabetic patients.
Erkelens DW; Dullaart R; Peuker N
Neth J Med; 1983; 26(1):1-9. PubMed ID: 6835443
[No Abstract] [Full Text] [Related]
27. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
[TBL] [Abstract][Full Text] [Related]
28. Sorbitol concentration in the plasma and erythrocytes of diabetic subjects.
Somers G; Depoorter I; Sener A; Malaisse WJ
Diabetes Care; 1982; 5(3):319-21. PubMed ID: 7173001
[TBL] [Abstract][Full Text] [Related]
29. Changes in serum and urinary myo-inositol levels in chronic glomerulonephritis.
Pitkänen E
Clin Chim Acta; 1976 Sep; 71(3):461-8. PubMed ID: 971534
[TBL] [Abstract][Full Text] [Related]
30. [Blood serum concentration and urinary excretion of myoinositol in patients with malignant tumors].
Trznadel K; Walasek L; Lutz W; Nagański T; Fajndt S
Pol Tyg Lek; 1977 Nov; 32(46):1785-7. PubMed ID: 593947
[No Abstract] [Full Text] [Related]
31. Myoinositol ameliorates high-fat diet and streptozotocin-induced diabetes in rats through promoting insulin receptor signaling.
Antony PJ; Gandhi GR; Stalin A; Balakrishna K; Toppo E; Sivasankaran K; Ignacimuthu S; Al-Dhabi NA
Biomed Pharmacother; 2017 Apr; 88():1098-1113. PubMed ID: 28192884
[TBL] [Abstract][Full Text] [Related]
32. Myoinositol incorporation into lymphocytes of chronic renal failure patients is impaired.
Bartnicki P; Luciak M; Zbróg Z; Tchórzewski H
Nephrol Dial Transplant; 1995; 10(5):637-42. PubMed ID: 7566575
[TBL] [Abstract][Full Text] [Related]
33. Effects of glucose and parathyroid hormone on the renal handling of myoinositol by isolated perfused dog kidneys.
Molitoris BA; Hruska KA; Fishman N; Daughaday WH
J Clin Invest; 1979 Jun; 63(6):1110-8. PubMed ID: 221533
[TBL] [Abstract][Full Text] [Related]
34. [Myoinositol levels in the serum and urine of healthy children].
Bednorz R
Pediatr Pol; 1985 Sep; 60(9):647-51. PubMed ID: 3831897
[No Abstract] [Full Text] [Related]
35. Urinary epidermal growth factor excretion is correlated to renal function loss per se and not to the degree of diabetic renal failure.
ter Meulen CG; Bilo HJ; van Kamp GJ; Gans RO; Donker AJ
Neth J Med; 1994 Jan; 44(1):12-7. PubMed ID: 8202200
[TBL] [Abstract][Full Text] [Related]
36. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.
Wollesen F; Brattström L; Refsum H; Ueland PM; Berglund L; Berne C
Kidney Int; 1999 Mar; 55(3):1028-35. PubMed ID: 10027940
[TBL] [Abstract][Full Text] [Related]
37. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
38. [Myoinositol].
Yamanouchi T
Nihon Rinsho; 2004 Nov; 62 Suppl 11():670-2. PubMed ID: 15628505
[No Abstract] [Full Text] [Related]
39. Somatostatin limits rise in glomerular filtration rate after a protein meal.
Brouhard BH; LaGrone LF; Richards GE; Travis LB
J Pediatr; 1987 May; 110(5):729-34. PubMed ID: 2883274
[TBL] [Abstract][Full Text] [Related]
40. Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol.
Pugliese G; Tilton RG; Speedy A; Santarelli E; Eades DM; Province MA; Kilo C; Sherman WR; Williamson JR
Diabetes; 1990 Mar; 39(3):312-22. PubMed ID: 2307293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
